Desonide: Difference between revisions

Jump to navigation Jump to search
No edit summary
No edit summary
Line 6: Line 6:
|indicationType=treatment
|indicationType=treatment
|indication=inflammatory and pruritic manifestations of corticosteroid responsive [[dermatoses]]
|indication=inflammatory and pruritic manifestations of corticosteroid responsive [[dermatoses]]
|adverseReactions=[[contact dermatitis]], dry skin, [[pruritus]], stinging of skin, burning sensation, [[irritation symptom]]
|adverseReactions=[[contact dermatitis]], dry skin, [[pruritus]], stinging of skin, burning sensation, irritation symptom
|blackBoxWarningTitle=<b><span style="color:#FF0000;">TITLE</span></b>
|blackBoxWarningTitle=<b><span style="color:#FF0000;">TITLE</span></b>
|blackBoxWarningBody=<i><span style="color:#FF0000;">Condition Name:</span></i> (Content)
|blackBoxWarningBody=<i><span style="color:#FF0000;">Condition Name:</span></i> (Content)

Revision as of 04:11, 23 November 2014

Desonide
Adult Indications & Dosage
Pediatric Indications & Dosage
Contraindications
Warnings & Precautions
Adverse Reactions
Drug Interactions
Use in Specific Populations
Administration & Monitoring
Overdosage
Pharmacology
Clinical Studies
How Supplied
Images
Patient Counseling Information
Precautions with Alcohol
Brand Names
Look-Alike Names

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Sheng Shi, M.D. [2]

Disclaimer

WikiDoc MAKES NO GUARANTEE OF VALIDITY. WikiDoc is not a professional health care provider, nor is it a suitable replacement for a licensed healthcare provider. WikiDoc is intended to be an educational tool, not a tool for any form of healthcare delivery. The educational content on WikiDoc drug pages is based upon the FDA package insert, National Library of Medicine content and practice guidelines / consensus statements. WikiDoc does not promote the administration of any medication or device that is not consistent with its labeling. Please read our full disclaimer here.

Overview

Desonide is a corticosteroid that is FDA approved for the treatment of inflammatory and pruritic manifestations of corticosteroid responsive dermatoses. Common adverse reactions include contact dermatitis, dry skin, pruritus, stinging of skin, burning sensation, irritation symptom.

Adult Indications and Dosage

FDA-Labeled Indications and Dosage (Adult)

Dermatoses

  • Dosing information
  • Desonide cream or ointment should be applied to the affected areas as a thin film two or four times daily depending on the severity of the condition.
  • As with other corticosteroids, therapy should be discontinued when control is achieved. If no improvement is seen within two weeks, reassessment of diagnosis may be necessary.
  • Desonide cream and ointment should not be used with occlusive dressings.

Off-Label Use and Dosage (Adult)

Guideline-Supported Use

There is limited information regarding Off-Label Guideline-Supported Use of desonide in adult patients.

Non–Guideline-Supported Use

There is limited information regarding Off-Label Non–Guideline-Supported Use of desonide in adult patients.

Pediatric Indications and Dosage

FDA-Labeled Indications and Dosage (Pediatric)

Safety and effectiveness in pediatric patients have not been established

Off-Label Use and Dosage (Pediatric)

Guideline-Supported Use

There is limited information regarding Off-Label Guideline-Supported Use of desonide in pediatric patients.

Non–Guideline-Supported Use

There is limited information regarding Off-Label Non–Guideline-Supported Use of desonide in pediatric patients.

Contraindications

Desonide cream and ointment are contraindicated in those patients with a history of hypersensitivity to any of the components of the preparations.

Warnings

There is limited information regarding Desonide Warnings' in the drug label.

Adverse Reactions

Clinical Trials Experience

There is limited information regarding Desonide Clinical Trials Experience in the drug label.

Postmarketing Experience

There is limited information regarding Desonide Postmarketing Experience in the drug label.

Drug Interactions

There is limited information regarding Desonide Drug Interactions in the drug label.

Use in Specific Populations

Pregnancy

Pregnancy Category (FDA): There is no FDA guidance on usage of Desonide in women who are pregnant.
Pregnancy Category (AUS): There is no Australian Drug Evaluation Committee (ADEC) guidance on usage of Desonide in women who are pregnant.

Labor and Delivery

There is no FDA guidance on use of Desonide during labor and delivery.

Nursing Mothers

There is no FDA guidance on the use of Desonide in women who are nursing.

Pediatric Use

There is no FDA guidance on the use of Desonide in pediatric settings.

Geriatic Use

There is no FDA guidance on the use of Desonide in geriatric settings.

Gender

There is no FDA guidance on the use of Desonide with respect to specific gender populations.

Race

There is no FDA guidance on the use of Desonide with respect to specific racial populations.

Renal Impairment

There is no FDA guidance on the use of Desonide in patients with renal impairment.

Hepatic Impairment

There is no FDA guidance on the use of Desonide in patients with hepatic impairment.

Females of Reproductive Potential and Males

There is no FDA guidance on the use of Desonide in women of reproductive potentials and males.

Immunocompromised Patients

There is no FDA guidance one the use of Desonide in patients who are immunocompromised.

Administration and Monitoring

Administration

There is limited information regarding Desonide Administration in the drug label.

Monitoring

There is limited information regarding Desonide Monitoring in the drug label.

IV Compatibility

There is limited information regarding the compatibility of Desonide and IV administrations.

Overdosage

There is limited information regarding Desonide overdosage. If you suspect drug poisoning or overdose, please contact the National Poison Help hotline (1-800-222-1222) immediately.

Pharmacology

There is limited information regarding Desonide Pharmacology in the drug label.

Mechanism of Action

There is limited information regarding Desonide Mechanism of Action in the drug label.

Structure

There is limited information regarding Desonide Structure in the drug label.

Pharmacodynamics

There is limited information regarding Desonide Pharmacodynamics in the drug label.

Pharmacokinetics

There is limited information regarding Desonide Pharmacokinetics in the drug label.

Nonclinical Toxicology

There is limited information regarding Desonide Nonclinical Toxicology in the drug label.

Clinical Studies

There is limited information regarding Desonide Clinical Studies in the drug label.

How Supplied

There is limited information regarding Desonide How Supplied in the drug label.

Storage

There is limited information regarding Desonide Storage in the drug label.

Images

Drug Images

{{#ask: Page Name::Desonide |?Pill Name |?Drug Name |?Pill Ingred |?Pill Imprint |?Pill Dosage |?Pill Color |?Pill Shape |?Pill Size (mm) |?Pill Scoring |?NDC |?Drug Author |format=template |template=DrugPageImages |mainlabel=- |sort=Pill Name }}

Package and Label Display Panel

{{#ask: Label Page::Desonide |?Label Name |format=template |template=DrugLabelImages |mainlabel=- |sort=Label Page }}

Patient Counseling Information

There is limited information regarding Desonide Patient Counseling Information in the drug label.

Precautions with Alcohol

Alcohol-Desonide interaction has not been established. Talk to your doctor about the effects of taking alcohol with this medication.

Brand Names

There is limited information regarding Desonide Brand Names in the drug label.

Look-Alike Drug Names

There is limited information regarding Desonide Look-Alike Drug Names in the drug label.

Drug Shortage Status

Price

References

The contents of this FDA label are provided by the National Library of Medicine.